Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans
- 17 May 2000
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 56 (2) , 167-174
- https://doi.org/10.1007/s002280050736
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: